OAC
IMMX icon

OMERS Administration Corp’s Immix Biopharma IMMX Stock Holding History

OMERS Administration Corp’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$186K Sell
20,400
-54,300
-73% -$399K ﹤0.01% 931
2025
Q4 		$391K Buy
+74,700
New +$307K ﹤0.01% 749

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

OMERS Administration Corp's IMMX Position: Q1 2026 in Review

OMERS Administration Corp reduced its Immix Biopharma (IMMX) stake by 73% in Q1 2026, selling an estimated $399K and leaving 20,400 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #931.

OMERS Administration Corp first reported a position in IMMX in Q4 2025 and has held it in 2 quarters since. The position peaked at $391K in Q4 2025. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • OMERS Administration Corp held 20,400 shares of Immix Biopharma worth $186K as of Q1 2026.
  • OMERS Administration Corp sold 54,300 Immix Biopharma shares in Q1 2026, an estimated $399K.
  • Immix Biopharma made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #931 holding.
  • OMERS Administration Corp first reported a position in Immix Biopharma in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Immix Biopharma position peaked at $391K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.